GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Liver Transplantation/Whole-Organ Donor Liver Assessment Using PS-OCT: Science Translational Medicine | July 2026
8

Whole-Organ Donor Liver Assessment Using PS-OCT: Science Translational Medicine | July 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated July 1, 2026

Introduction:

Liver transplantation is limited by a shortage of suitable donor organs. Current viability assessment relies on needle biopsy, which samples only a small portion of the liver and may miss important regional pathology. This study evaluated polarization-sensitive optical coherence tomography (PS-OCT), a noninvasive imaging technique, for comprehensive whole-organ donor liver assessment.

Why was this study needed?

  • Liver biopsy samples only a tiny fraction of the donor liver and may overlook heterogeneous disease.
  • Better methods are needed to accurately assess extended-criteria donor livers.
  • Inaccurate assessment can lead to unnecessary organ discard or transplantation of poor-quality grafts.
  • Whole-organ, noninvasive viability assessment has remained an unmet need.
  • Artificial intelligence may improve interpretation of advanced imaging data.

Results:

  • PS-OCT accurately assessed steatosis, fibrosis, inflammation, and necrosis across the entire donor liver, showing excellent agreement with conventional histopathology.
  • PS-OCT findings closely correlated with liver function during normothermic machine perfusion and with early post-transplant clinical outcomes, supporting its clinical relevance.
  • By providing rapid, noninvasive whole-organ assessment, PS-OCT has the potential to reduce unnecessary organ discard while improving donor liver selection.

Clinical Impact:

This study represents a major advance in donor liver evaluation. PS-OCT combines high-resolution imaging with artificial intelligence to assess the entire liver rather than a small biopsy sample, potentially improving transplant decision-making and expanding the usable donor pool.

Bottom Line:

PS-OCT may redefine donor liver viability assessment. By providing accurate, noninvasive, whole-organ evaluation that correlates with graft function and transplant outcomes, it has the potential to reduce organ discard and safely expand liver transplantation.

Related Q&A

09

Personalizing Antifibrinolytic Use in Liver Transplantation : Liver Transpl | Jul 2026

Introduction: Bleeding remains a major challenge during liver transplantation despite advances in surgical techniques, anesthesia, and perioperative care. Antifibrinolytic agents have long been used to reduce intraoperative blood...

10

Integrating LDLT into Modern Liver Transplant Programs: Liver Transplantation | June 2026

Introduction: The demand for liver transplantation continues to exceed the availability of deceased donor organs, resulting in prolonged waiting times and preventable waitlist mortality. This perspective discusses how...

11

Post-Transplant Management in Pediatric LT: Liver Transplantation | June 2026

Introduction: Pediatric liver transplantation has achieved excellent survival rates, shifting the focus from graft survival alone to optimising long-term health, growth, neurodevelopment, and quality of life. This updated...

12

IBAT Inhibitor Relieves Refractory ICP After Liver Transplant : Liver Transpl | Jun 2026

Introduction: Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific liver disorder characterized by severe pruritus and elevated bile acids, carrying risks for both maternal well-being and fetal outcomes....

13

Post-Transplant Infections Drive Early Readmissions : Liver Transpl | Apr 2026

Introduction: Hospital readmission within 30 days of liver transplantation is a common and costly event that reflects early postoperative morbidity and is increasingly used as a quality metric...

14

Frailty at 1 Year Predicts Long-Term Mortality After Liver Transplant : Liver Transpl | June 2026

Introduction: Frailty is increasingly recognized as a key determinant of outcomes in patients with advanced liver disease and has become an important component of liver transplant evaluation. Although...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer